{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:26:21Z","timestamp":1792113981929,"version":"4.4.0"},"reference-count":39,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2021.0012","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T07:56:01Z","timestamp":1612338961000},"source":"Crossref","is-referenced-by-count":12,"title":["Infarction-Related Cardiogenic Shock\u2014 Diagnosis, Monitoring and Therapy"],"prefix":"10.3238","author":[{"given":"Karl","family":"Werdan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Buerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Geppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Zwissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ru\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"10.3238\/arztebl.m2021.0012_ref1","doi-asserted-by":"crossref","unstructured":"Scholz KH, Maier SKG, Maier LS, et al.: Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J 2018; 39: 1065\u201374","DOI":"10.1093\/eurheartj\/ehy004"},{"key":"10.3238\/arztebl.m2021.0012_ref2","doi-asserted-by":"crossref","unstructured":"Werdan K, Ru\u00df M, Buerke M, Delle-Karth G, Geppert A, Sch\u00f6ndube FA: Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment. A German-Austrian S3 guideline. Dtsch Arztebl Int 2012; 109: 343\u201351","DOI":"10.3238\/arztebl.2012.0343"},{"key":"10.3238\/arztebl.m2021.0012_ref3","doi-asserted-by":"crossref","unstructured":"Zeymer U, Bueno H, Granger CB, et al.: Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: a document of the Acute Cardiovascular Care Association of the European Society of Cardiology. EHJ Acute Cardiovasc Care 2020; 9: 183\u201397","DOI":"10.1177\/2048872619894254"},{"key":"10.3238\/arztebl.m2021.0012_ref4","unstructured":"Werdan K, Ru\u00df M, Boeken U, et al: Infarkt-bedingter kardiogener Schock \u2013 Diagnose, Monitoring und Therapie. S3-Leitlinie. AWMF-RN 019\u2013013. AWMF 2019. https:\/\/www.awmf.org\/leitlinien\/detail\/ll\/019-013.html (last accessed on 28 December 2020)."},{"key":"10.3238\/arztebl.m2021.0012_ref5","doi-asserted-by":"crossref","unstructured":"Thiele H, Ohman EM, de Waha-Thiele S, et al.: Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur Heart J 2019; 40: 2671\u201383","DOI":"10.1093\/eurheartj\/ehz363"},{"key":"10.3238\/arztebl.m2021.0012_ref6","doi-asserted-by":"crossref","unstructured":"Bangalore S, Gupta N, Guo Y, et al.: Outcomes with invasive vs. conservative management of cardiogenic shock complicating acute myocardial infarction. Am J Med 2015; 128: 601\u20138","DOI":"10.1016\/j.amjmed.2014.12.009"},{"key":"10.3238\/arztebl.m2021.0012_ref7","doi-asserted-by":"crossref","unstructured":"Thiele H, Akin I, Sandri M, et al.: PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med 2017; 377: 2419\u201332","DOI":"10.1056\/NEJMoa1710261"},{"key":"10.3238\/arztebl.m2021.0012_ref8","doi-asserted-by":"crossref","unstructured":"White HD, Assmann SF, Sanborn TA, et al.: Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the should we emergently revascularize occluded coronaries for cardiogenic shock (SHOCK) trial. Circulation 2005; 112: 1992\u20132001","DOI":"10.1161\/CIRCULATIONAHA.105.540948"},{"key":"10.3238\/arztebl.m2021.0012_ref9","doi-asserted-by":"crossref","unstructured":"Zeymer U, Hochadel M, Karcher A-K, et al.: Procedural success rates and mortality in elderly patients with percutaneous coronary intervention for cardiogenic shock. JACC Cardiovasc Interv 2019; 12: 1853\u20139","DOI":"10.1016\/j.jcin.2019.04.027"},{"key":"10.3238\/arztebl.m2021.0012_ref10","doi-asserted-by":"crossref","unstructured":"Thiele H, Zeymer U, Neumann F-J, et al., for the IABP-SHOCK II Trial Investigators: Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287\u201396","DOI":"10.1056\/NEJMoa1208410"},{"key":"10.3238\/arztebl.m2021.0012_ref11","doi-asserted-by":"crossref","unstructured":"Zeymer U, Schneider S, Zahn R, et al.: Impact of pre-hospital resuscitation on short- and long-term mortality in patients with cardiogenic shock undergoing revascularization: results of IABP-SHOCK study. J Am Coll Cardiol 2018; 71 (11 Suppl): 198 Presentation Number 1262\u2013456","DOI":"10.1016\/S0735-1097(18)30739-3"},{"key":"10.3238\/arztebl.m2021.0012_ref12","doi-asserted-by":"crossref","unstructured":"Michels G, Wengenmayer T, Hagl C, et al.: Empfehlungen zur extrakorporalen kardiopulmonalen Reanimation (eCPR): Konsensuspapier der DGIIN, DGK, DGTHG, DGfK, DGNI, DGAI, DIVI und GRC. Med Klin Intensivmed Notfmed 2018; 113: 478\u201386","DOI":"10.1007\/s00063-018-0452-8"},{"key":"10.3238\/arztebl.m2021.0012_ref13","doi-asserted-by":"crossref","unstructured":"Pichler P, Antretter H, D\u00fcnser M, et al.: Positionspapier der \u00d6sterreichischen Kardiologischen Gesellschaft zum Einsatz der extrakorporalen Membranoxygenation (ECMO) bei Erwachsenen kardiologischen Patienten. Wien Klin Wochenschr 2015; 127: 169\u201384","DOI":"10.1007\/s00508-015-0743-5"},{"key":"10.3238\/arztebl.m2021.0012_ref14","doi-asserted-by":"crossref","unstructured":"Levy B, Clere-Jehl R, Legras A, et al.: Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 2018; 72: 173\u201382","DOI":"10.1016\/j.jacc.2018.04.051"},{"key":"10.3238\/arztebl.m2021.0012_ref15","doi-asserted-by":"crossref","unstructured":"Prondzinsky R, Lemm H, Swyter M, et al.: Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 2010; 38: 152\u201360","DOI":"10.1097\/CCM.0b013e3181b78671"},{"key":"10.3238\/arztebl.m2021.0012_ref16","doi-asserted-by":"crossref","unstructured":"Prondzinsky R, Unverzagt S, Russ M, et al.: Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK trial. Shock 2012; 37: 378\u201384","DOI":"10.1097\/SHK.0b013e31824a67af"},{"key":"10.3238\/arztebl.m2021.0012_ref17","doi-asserted-by":"crossref","unstructured":"Unverzagt S, Buerke M, de Waha A, et al.: Intra-aortic balloon pump counter-pulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev 2015; 3: CD007398","DOI":"10.1002\/14651858.CD007398.pub3"},{"key":"10.3238\/arztebl.m2021.0012_ref18","doi-asserted-by":"crossref","unstructured":"Schrage B, Ibrahim K, Loehn T, et al.: Impella support for acute myocardial infarction complicated by cardiogenic shock: a matched-pair IABP-SHOCK II trial 30-day mortality analysis. Circulation 2019; 139: 1249\u201358","DOI":"10.1161\/CIRCULATIONAHA.118.036614"},{"key":"10.3238\/arztebl.m2021.0012_ref19","doi-asserted-by":"crossref","unstructured":"Thiele H, Jobs A, Ouweneel DM, et al.: Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials. Eur Heart J 2017; 38: 3523\u201331","DOI":"10.1093\/eurheartj\/ehx363"},{"key":"10.3238\/arztebl.m2021.0012_ref20","doi-asserted-by":"crossref","unstructured":"Tramm R, Ilic D, Davies AR, et al.: Extracorporeal membrane oxygenation for critically ill adults. Cochrane Database Syst Rev 2015; 1: CD010381","DOI":"10.1002\/14651858.CD010381.pub2"},{"key":"10.3238\/arztebl.m2021.0012_ref21","doi-asserted-by":"crossref","unstructured":"Ouweneel DM, Schotborgh JV, Limpens J, et al.: Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Med 2016; 42: 1922\u201334","DOI":"10.1007\/s00134-016-4536-8"},{"key":"10.3238\/arztebl.m2021.0012_ref22","doi-asserted-by":"crossref","unstructured":"Formica F, Mariani S, D\u2019Alessanmdro S: Acute mechanical complications in patients suffering from acute myocardial infarction. Vessels Plus 2019; 3: 37","DOI":"10.20517\/2574-1209.2019.19"},{"key":"10.3238\/arztebl.m2021.0012_ref23","doi-asserted-by":"crossref","unstructured":"Schlotter F, de Waha S, Eitel I, et al.: Interventional post-myocardial infarction ventricular septal defect closure: a systematic review of current evidence. EuroIntervention 2016; 12: 94\u2013102","DOI":"10.4244\/EIJV12I1A17"},{"key":"10.3238\/arztebl.m2021.0012_ref24","unstructured":"Adamzik M, Bauer A, Bein T, et al.: Invasive Beatmung und Einsatz extrakorporaler Verfahren bei akuter respiratorischer Insuffizienz. S3-Leitlinie. AWMF-RN 001\/021. 1th edition. Stand 05.12.2017. www.awmf.org\/uploads\/tx_szleitlinien\/001-021l_S3_Invasive_Beatmung_2017-12.pdf (last accessed on 30 December 2020)."},{"key":"10.3238\/arztebl.m2021.0012_ref25","doi-asserted-by":"crossref","unstructured":"Guo L, Wang W, Zhao N, et al.: Mechanical ventilation strategies for intensive care unit patients without acute lung injury or acute respiratory distress syndrome: a systematic review and network meta-analysis. Crit Care 2016; 20: 226","DOI":"10.1186\/s13054-016-1396-0"},{"key":"10.3238\/arztebl.m2021.0012_ref26","doi-asserted-by":"crossref","unstructured":"Simonis G, Steiding K, Schaefer K, et al.: A prospective, randomized trial of continuous lateral rotation (\u201dkinetic therapy\u201d) in patients with cardiogenic shock. Clin Res Cardiol 2012; 101: 955\u201362 CrossRef","DOI":"10.1007\/s00392-012-0484-7"},{"key":"10.3238\/arztebl.m2021.0012_ref27","doi-asserted-by":"crossref","unstructured":"Dres M, Teboul JL, Monnet X: Weaning the cardiac patient from mechanical ventilation. Curr Opin Crit Care 2014; 20: 493\u20138","DOI":"10.1097\/MCC.0000000000000131"},{"key":"10.3238\/arztebl.m2021.0012_ref28","doi-asserted-by":"crossref","unstructured":"Lauridsen MD, Gammelager H, Schmidt M, et al.: Acute kidney injury treated with renal replacement therapy and 5-year mortality after myocardial infarction-related cardiogenic shock: a nationwide population-based cohort study. Crit Care 2015; 19: 452","DOI":"10.1186\/s13054-015-1170-8"},{"key":"10.3238\/arztebl.m2021.0012_ref29","doi-asserted-by":"crossref","unstructured":"Barilla F, Pannarale G, Torromeo C, et al.: Ivabradine in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a preliminary randomized prospective study. Clin Drug Investig 2016; 36: 849\u201356","DOI":"10.1007\/s40261-016-0424-9"},{"key":"10.3238\/arztebl.m2021.0012_ref30","doi-asserted-by":"crossref","unstructured":"Bjarnason-Wehrens B, Held K, Hoberg E, et al.: Deutsche Leitlinie zur Rehabilitation von Patienten mit Herz-Kreislauferkrankungen (DLL-KardReha). Clin Res Cardiol Supplements 2007; 2: III\/1-III\/54. Aktualisierung: S3\u2013Leitlinie zur kardiologischen Rehabilitation (LL-KardReha) im deutschsprachigen Raum Europas. Deutschland, \u00d6sterreich, Schweiz (D-A-CH), Langversion \u2013 Teil 1, 2019 AWMF-RN: 133\/001, www.awmf.org\/uploads\/tx_szleitlinien\/133-001k_S3-Kardiologische-Rehabilitation-in-D-A-CH_2020-12.pdf (last accessed on 12 December 2020)","DOI":"10.1007\/s11789-007-0001-0"},{"key":"10.3238\/arztebl.m2021.0012_ref31","doi-asserted-by":"crossref","unstructured":"Thiele H, Zeymer U, Thelemann N, et al.: Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomized IABP-SHOCK II trial. Circulation 2019; 139: 395\u2013403","DOI":"10.1161\/CIRCULATIONAHA.118.038201"},{"key":"10.3238\/arztebl.m2021.0012_ref32","doi-asserted-by":"crossref","unstructured":"Karagiannidis C, Windisch W: Epidemiologie und Mortalit\u00e4t der Herz- und Lungenersatzverfahren in Deutschland zwischen 2007 und 2014. (Letter). Med Klin Intensivmed Notfmed 2016; 111: 556\u20139","DOI":"10.1007\/s00063-016-0207-3"},{"key":"10.3238\/arztebl.m2021.0012_ref33","doi-asserted-by":"crossref","unstructured":"Van Diepen S, Hochman JS, Stebbins A, et al.: Association between delays in mechanical ventilation initiation and mortality in patients with refractory cardiogenic shock. JAMA Cardiol 2020; 5: 965\u2013","DOI":"10.1001\/jamacardio.2020.1274"},{"key":"10.3238\/arztebl.m2021.0012_ref34","doi-asserted-by":"crossref","unstructured":"Schneck M, Hoder K, Gielen S, et al.: Lung protective ventilation and hospital survival of cardiac intensive care patients. Med Klin Intensivmed Notfmed 2016; 111: 508\u201313","DOI":"10.1007\/s00063-015-0105-0"},{"key":"10.3238\/arztebl.m2021.0012_ref35","doi-asserted-by":"crossref","unstructured":"Reintam Blaser A, Malbrain ML, Starkopf J, et al.: Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems. Intensive Care Med 2012; 38: 384\u201394","DOI":"10.1007\/s00134-011-2459-y"},{"key":"10.3238\/arztebl.m2021.0012_ref36","doi-asserted-by":"crossref","unstructured":"Werdan K, Boeken U, Briegel J, et al.: Infarktbedingter kardiogener Schock \u2013 Diagnose, Monitoring und Therapie. S3-Leitlinie. Intensiv- und Notfallbehandlung 2021; 46, in print.","DOI":"10.5414\/IBX00547"},{"key":"10.3238\/arztebl.m2021.0012_ref37","doi-asserted-by":"crossref","unstructured":"Reignier J, Boisram\u00e9-Helms J, Brisard L, et al.: Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2). Lancet 2018; 391: 133\u201343","DOI":"10.1016\/S0140-6736(17)32146-3"},{"key":"10.3238\/arztebl.m2021.0012_ref38","doi-asserted-by":"crossref","unstructured":"Heyland D, Muscedere J, Wischmeyer PE, et al.: A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 2013; 368: 1489\u201397","DOI":"10.1056\/NEJMoa1212722"},{"key":"10.3238\/arztebl.m2021.0012_ref39","doi-asserted-by":"crossref","unstructured":"The PEPTIC Investigators for the Australian and New Zealnad Intensive Care Society Clinical Trials Group. Alberta Health Services Critical Care Strategic Clinical Network, and the Irish Critical Care Trials Group: Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine-2 receptor blockers on in-hospital mortality among ICU patients receiving invasive mechanical ventilation. The PEPTIC Randomized Clinical Trial. JAMA 2020; 323: 616\u201326","DOI":"10.1001\/jama.2019.22190"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2021.0012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T09:36:15Z","timestamp":1638783375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2021.0012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":39,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2021.0012","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]}}}